AzTrials
AzTrials

Inferior Vena CavaNCT07399093

Preoperative Evaluation of IVC Collapsibility Index and Caval Aorta Index After Induction of General Anesthesia

An observational study of Inferior Vena Cava and Collapsibility Index, run by Ain Shams University at 1 site in Egypt.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to assess the accuracy, repeatability, and reproducibility of preoperative evaluation of Inferior Vena Cava (IVC) collapsibility index and caval aorta index for prediction of hypotension after induction of general anesthesia. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
What is being tested?
Inferior vena cava collapsibility index and Caval Aorta Index
How many people
36 participants
Where
1 siteEgypt
Study dates
14 Jan 2024to 1 Mar 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: This prospective cohort study will be conducted on 40 patients undergoing craniotomy surgeries at Ain Shams University Hospitals.

Who may be able to join

  • Age from 18 to 40 years.
  • Both sexes.
  • Body Mass Index< 40 kg/m².
  • American Society of Anesthesiologists (ASA) physical status I, II.
  • Fasted according to the ASA guidelines: 2 hours for clear fluids, 6 hours after light meal, 8 hours after a full meal with high calorie or fat content.
  • Scheduled for elective craniotomy surgeries before induction of general anesthesia.

Who cannot join

  • Current or recent pregnancy (within 3 months).
  • Pre-existing cardiac disease or hypertension.
  • On medications affecting blood pressure [Beta-blockers (BBs) and calcium channel blockers (CCBs)] .
  • Refusing to undergo the study.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Egypt1 site, 1 recruiting
  • Ain Shams University Hospitals

    Cairo, 11591

    Verina F Bekheet, MSc, 00201098858385, verina.fares@med.asu.edu.eg

    Sherif W Sarguios, MD

    Recruiting

Other trials in Egypt

About this study

Official title: Preoperative Evaluation of IVC Collapsibility Index and Caval Aorta Index for Prediction of Hypotension After Induction of General Anesthesia in Patients Undergoing Craniotomy Surgeries

This study aims to assess the accuracy, repeatability, and reproducibility of preoperative evaluation of Inferior Vena Cava (IVC) collapsibility index and caval aorta index for prediction of hypotension after induction of general anesthesia.

Read the detailed description

Post- anesthesia hypotension is of common occurrence, and it hampers tissue perfusion. The magnitude of hypotension is determined by the preoperative volume status, which varies depending on American Society of Anesthesiologists (ASA) physical status, preoperative comorbidities, preoperative medications, and fasting.

General anesthesia causes significant alterations in hemodynamics, as both inhalational and intravenous anesthetics cause bradycardia, decrease in systemic vascular resistance and vasodilatation, and decrease in myocardial contractility, cardiac output and stroke volume, with the absence of surgical stimulus, making induction of anesthesia is the most crucial period at which hypotension occurs.

Due to different definitions of hypotension and diverse patient populations, the effect of volume preload on prevention of hypotension is still controversial. Many recommendations to identified sonographic determination of inferior vena cava (IVC) collapsibility index (IVCCI) as non-invasive, and easy technique for evaluating volume status. Recent guidelines from the American Society of Echocardiography support the general use of IVCCI in assessing volume status.

Being tested
Inferior vena cava collapsibility index, Caval Aorta Index

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Inferior vena cava collapsibility indexOther

    Inferior vena cava (IVC) collapsibility index (IVCCI) will be measured.

    The IVCCI is calculated using the following formula:

    IVCCI = (maximum IVC diameter - minimum IVC diameter) / maximum IVC diameter * 100

  • Caval Aorta IndexOther

    The Inferior vena cava (IVC): Ao index will be derived by taking the ratio of the maximum IVC diameter during expiration and the maximal abdominal aortic diameter during systole.

    • The caval aorta index (IVC/Ao) is calculated using the following formula: IVC/Ao index = IVC diameter / aortic diameter.
Study groups in NCT07399093
Study groupRoleWhat they receive
Study groupPatients scheduled for elective craniotomy surgeries before induction of general anesthesia.
Receives: Other: Inferior vena cava collapsibility index; Other: Caval Aorta Index

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sensitivity of ultrasound guided Aorto-Caval index (IVC-AO)

    Sensitivity of ultrasound guided Aorto-Caval index (IVC-AO) to predict hypotension will be recorded.

    Measured: 15 minutes post-induction of general anesthesia.

Secondary outcomes (3)
  1. Specificity of ultrasound guided Aorto-Caval index (IVC-AO)

    Specificity of ultrasound guided Aorto-Caval index (IVC-AO) to predict hypotension will be recorded.

    Measured: 15 minutes post-induction of general anesthesia.

  2. Sensitivity of inferior vena cava (IVC) collapsibility index

    Sensitivity of inferior vena cava (IVC) collapsibility index to predict hypotension will be recorded.

    Measured: 15 minutes post-induction of general anesthesia.

  3. Specificity of inferior vena cava (IVC) collapsibility index

    Specificity of inferior vena cava (IVC) collapsibility index to predict hypotension will be recorded.

    Measured: 15 minutes post-induction of general anesthesia.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Feb 2026
  2. Study start14 Jan 2024
  3. Primary completion1 Mar 2026 (estimated)
  4. Study completion1 Mar 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
36 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07399093
Sponsor's protocol ID
FMASU MD08/2024
Status last verified
Feb 2026
First submitted
24 Jul 2025
Last updated
10 Feb 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Questions about this trial

What is this clinical trial studying?

An observational study of Inferior Vena Cava and Collapsibility Index, run by Ain Shams University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 10 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Verina F Zaref, MSc (00201098858385, verina.fares@med.asu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sensitivity of ultrasound guided Aorto-Caval index (IVC-AO) (time frame: 15 minutes post-induction of general anesthesia.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in